Catalyst Wire Dossier Catalyst Wire Dossier

Non-polymer-based, rapamycin-eluting stents

rapamycin-eluting stents · Translumina GmbH
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Non-polymer-based, rapamycin-eluting stents, covering 2020-10-08 to 2020-10-08. Get the full timeline:

Most recent: Clinical Trial Update: Non-Polymer-Based, Rapamycin-Eluting Stents to Prevent Restenosis [Phase 4]

See pricing